Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-03

Clinical Trial Update: CYstic Fibrosis bacterioPHage Study at Yale (CYPHY) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for a bacteriophage therapy targeting cystic fibrosis conducted at Yale (CYPHY) with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYstic Fibrosis bacterioPHage Study (CYPHY) (bacteriophage therapy)

Snippet

Sponsor: Yale University | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-03-03